Reconstituting Semaglutide 5mg: What the Term Means and Why It Matters

What does reconstituting a medicine actually involve, and why does it not apply to licensed Wegovy?

Reconstitution is a pharmaceutical process: a powdered (lyophilised) drug is combined with a specific volume of sterile diluent, usually bacteriostatic water, to create an injectable solution. It requires precise measurement, sterile technique, and knowledge of the correct concentration, a task normally carried out by a trained pharmacist or healthcare professional, not at home.

Wegovy, which is the only semaglutide product licensed in the UK for weight management, bypasses this entirely. Each pen contains a pre-measured, pre-dissolved solution ready for subcutaneous injection. You take it from the fridge door, let it reach room temperature for a few minutes, and inject, no vials, no syringes, no calculations. The NHS patient information on semaglutide reflects this: the instructions describe attaching a needle to the pen and dialling a dose, not preparing a solution from powder.

This matters because the reconstitution process, when done incorrectly, introduces serious hazards: inaccurate concentrations leading to under- or over-dosing, microbial contamination from non-sterile technique, and instability from improper storage of the reconstituted solution. These are not theoretical risks. They are the practical reasons regulatory agencies insist on manufacturer-prepared, validated formulations for patient use.

If you have found instructions for reconstituting a 5mg semaglutide powder, those instructions relate to a product that has not been assessed, approved, or licensed by the MHRA for use in UK patients. You can read more about how Wegovy's licensed dose schedule works and what each strength is designed to do.

Where does the "semaglutide 5mg reconstitution" idea come from?

The term has spread for a specific reason: compounding pharmacies, predominantly in the United States and Australia, have produced semaglutide in powdered vial form during periods of Wegovy supply shortage. Those products are supplied with instructions telling patients how to mix them at home. That practice is legal in some jurisdictions under their own regulatory frameworks; it is not legal or endorsed in the UK.

In the UK, compounded medicines can only be prepared by a licensed manufacturer or a registered pharmacy under tightly controlled conditions, and they cannot be prepared as a substitute for a licensed product that is available on the market. Wegovy has been available in the UK since 2023. Compounded semaglutide therefore has no legitimate patient-facing role here.

The MHRA has explicitly warned that fake and unlicensed weight-loss injection products are circulating online, and the agency has carried out significant enforcement action, including the seizure of approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million. Products sold without a valid prescription through unverified online sellers are a documented safety risk. You can report any suspect seller directly via the MHRA's Yellow Card scheme.

Understanding where to source Wegovy safely in the UK is the practical next step if you have been trying to navigate this.

What are the licensed Wegovy dose strengths, and how does titration actually work?

For anyone who arrived here wanting to understand dosing, here is the licensed picture. Wegovy's titration ladder begins at 0.25mg weekly, a starting dose chosen to help the body adjust, not to produce weight loss immediately. From there, the prescriber typically moves through 0.5mg, 1.0mg, and 1.7mg, with roughly four weeks at each level, before reaching the standard 2.4mg maintenance dose. In April 2026, the MHRA approved a dedicated 7.2mg single-dose pen as the new maximum for adults with a BMI of 30 or above.

None of these strengths is 5mg. The 5mg figure does not appear anywhere in the Wegovy SmPC, the NICE guidance for semaglutide (TA875), or the licensed patient information. If you are curious about what the 5mg semaglutide reconstitution process actually involves and why it sits outside the licensed framework, that page explains it in detail, but that product is not Wegovy and is not covered by any UK marketing authorisation.

For a fuller picture of the dose options used in obesity treatment and how they are chosen, that page goes into more clinical detail. The titration schedule, missed-dose guidance, and decisions about changing strength all belong to the prescriber and the patient information leaflet that comes with each licensed pen, not to generic online instructions.

What should you do if you want semaglutide for weight management in the UK?

The route is a clinical consultation, followed by a prescription from a qualified prescriber, filled by a GPhC-registered pharmacy sourcing from the licensed UK supply chain. There is no shortcut that is both legal and safe.

At our pharmacy, every consultation is read personally by a GPhC-registered Independent Prescriber, a real clinician, not a questionnaire processor. Identity is verified, weight is confirmed, and the clinical picture is reviewed before any prescription is issued. If semaglutide is appropriate, the pen dispatched is a licensed Wegovy pen, manufactured to MHRA standards, stored and shipped correctly.

You can explore the weight-loss treatment options we prescribe, or read about Wegovy specifically, including how it works and what the clinical trial evidence shows. If you have questions before starting, our FAQs cover the most common ones. When you are ready, speaking to our prescribers is the right next step.